Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Axovant Sciences Ltd.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Axovant Sciences Ltd. since year 2005.
Table 2 shows the detailed insider transactions of Axovant Sciences Ltd. since 2005.
The reporting company's ticker symbol is AXON. The reporting company's CIK number is 1636050.
The total value of stock buying since 2005 is $12,025,616.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2017-04-17||Vernon W Anthony (Director)||Buy||53,937||18.54||999,991|
|2017-04-17||Hung David (Principal Executive Officer)||Buy||539,375||18.54||10,000,012|
|2017-04-17||Falberg Kathryn E (Director)||Buy||53,937||18.54||999,991|
|2016-03-10||Altmeyer Mark (Pres&Chief Commercial Officer)||Buy||2,300||11.14||25,622|
Insider trading activities including stock purchases, stock sales, and option exercises of AXON listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Axovant Sciences Ltd. (symbol AXON, CIK number 1636050) see the Securities and Exchange Commission (SEC) website.